Thinking of joining a study?

Register your interest

NCT05297305 | RECRUITING | Arthritis Shoulder


Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty
Sponsor:

William Beaumont Hospitals

Information provided by (Responsible Party):

Dr. Alex Martusiewicz

Brief Summary:

The goal of this study is to compare the effect of different ways to place the component that goes at the top of the humerus (upper arm) in reverse total shoulder replacement. Some surgeons place the humeral tray component sitting on the bone while others place it in the bone. Changing the way that the humeral component is placed may change how much the arm can raise up or turn out/in after surgery for some patients. This study compares patients with inlay humeral component (tray sits in the upper arm bone) versus onlay humeral component (tray sits on top of the upper arm bone) to see if there are differences in range of motion or function after surgery.

Condition or disease

Arthritis Shoulder

Rotator Cuff Injuries

Intervention/treatment

Tornier Ascend Flex stem

Tornier Perform Stem Reverse+

Phase

NA

Detailed Description:

This study aims to determine if active external rotation two years postoperatively varies based on whether an inlay or onlay humeral component is used in reverse shoulder arthroplasty (RTSA). The study also aims to determine whether active forward elevation, abduction, scapular notching, and functional outcomes two years postoperatively vary based on whether an inlay or onlay humeral component is used in reverse shoulder arthroplasty. Patients undergoing primary RTSA by Dr. J. Michael Wiater, Dr. Brett Wiater, or Dr. Alexander Martusiewicz at Beaumont Health will be screened for eligibility. Following informed consent, participants will be randomised (1:1) to one of the following groups: 1) RTSA with inlay humeral component (Tornier Perform Stem Reverse+) or 2) RTSA with onlay humeral component (Tornier Ascend Flex stem). At baseline, participants will complete study questionnaires, receive a range-of-motion (ROM) exam, and standard of care x-rays and computed tomography (CT) scans. These evaluations will be repeated at 3 months, 12 months and 24 months.

Study Type : INTERVENTIONAL
Estimated Enrollment : 154 participants
Masking : DOUBLE
Masking Description : Key personnel not collecting data will perform randomization and inform surgeon of the group assignment, keeping data collection blinded. The participant will also remain blinded to their assignment.
Primary Purpose : TREATMENT
Official Title : Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty: A Prospective, Randomized Trial
Actual Study Start Date : 2023-10-20
Estimated Primary Completion Date : 2025-12
Estimated Study Completion Date : 2025-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patients undergoing primary reverse total shoulder arthroplasty with the following components
    • 1. Onlay group: Ascend Flex stem, Perform Reversed standard +3 lateralized 25mm baseplate with standard 36 mm glenosphere or +6 lateralized 25mm baseplate with 39mm glenosphere
    • 2. Inlay group: Perform Stem Reverse, Perform Reversed +3 lateralized 25mm baseplate with standard 36mm glenosphere or +6 lateralized 25mm baseplate with 39mm glenosphere
    • * Diagnosis of cuff tear arthropathy, massive cuff tear, or primary osteoarthritis with cuff tear
    • * Negative external rotation lag sign, ability to externally rotate beyond neutral
    • * Age 18 years or older
    Exclusion Criteria
    • * Revision arthroplasty
    • * Prior open shoulder surgery
    • * Concomitant tendon transfer (Latissimus Dorsi, Pectoralis Tendon, Lower Trapezius)
    • * Diagnosis of rheumatoid arthritis, infection, acute trauma or instability
    • * Patients not willing to undergo a standardized physical therapy protocol or home therapy program after surgical intervention
    • * Patient anatomy does not accommodate the study implants per surgeon discretion
    • * Pregnant, patient-reported
    • * Minors (under 18 years of age)
    • * Cognitively impaired based on a diagnosis of dementia, psychiatric disorder, or any cognitive deficit that will not allow for proper informed consent or answering of study questionnaires

Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty

Location Details

NCT05297305


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Michigan

William Beaumont Hospital

Royal Oak, Michigan, United States, 48073

Loading...